SCHEMBL2118090

SCHEMBL2118090

C[Si](C)(C)OC[C@H]1O[C@H](OCCBr)[C@@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743606 1.00 — —
SCHEMBL16518077 1.00 — —
SCHEMBL931604 0.88 — —
SCHEMBL931603 0.83 LGALS8 (0.32) —
SCHEMBL16518072 0.83 LGALS8 (0.32) —
SCHEMBL2521899 0.82 — —
SCHEMBL17326130 0.82 — —
SCHEMBL19306301 0.82 — —
SCHEMBL2527021 0.82 — —
SCHEMBL13925626 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448600-B1 COMPOUNDS TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE (FR) 2016-03-30 — — EP disclosed
US-8962573-B2 Compounds targeting the cation-independent mannose 6-phosphate receptor INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2015-02-24 — — US disclosed
US-20120093795-A1 COMPOUNDS TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2012-04-19 — — US disclosed
Send feedback